Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Each year, the PM5 program will offer two different immunohistochemistry markers to evaluate assay performance on a wide variety of tissues and/or tumor types. The IHC markers for this program may change from those listed above due to development constraints.
Program Information
- Two 10‑core tissue microarray slides, one for CEA and one for PRAME